Patents by Inventor Jay B. Lichter

Jay B. Lichter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genotyping of human CYP3A4
    Publication number: 20030059800
    Abstract: Genetic polymorphisms are identified in the human CYP3A4 gene that alter CYP3A4-dependent drug metabolism. Nucleic acids comprising the polymorphic sequences are used to screen patients for altered metabolism for CYP3A4 substrates, potential drug-drug interactions, and adverse/side effects, as well as diseases that result from environmental or occupational exposure to toxins. The nucleic acids are used to establish animal, cell and in vitro models for drug metabolism.
    Type: Application
    Filed: May 14, 2002
    Publication date: March 27, 2003
    Applicant: DNA Sciences Laboratories, Inc.
    Inventors: Jay B. Lichter, Marco Guida
  • Isolated CYP3A4 nucleic acid molecules and detection methods
    Patent number: 6432639
    Abstract: Genetic polymorphisms are identified in the human CYP3A4 gene that alter CYP3A4-dependent drug metabolism. Nucleic acids comprising the polymorphic sequences are used to screen patients for altered metabolism for CYP3A4 substrates, potential drug-drug interactions, and adverse/side effects, as well as diseases that result from environmental or occupational exposure to toxins. The nucleic acids are used to establish animal, cell and in vitro models for drug metabolism.
    Type: Grant
    Filed: August 31, 1998
    Date of Patent: August 13, 2002
    Assignee: DNA Sciences Laboratories, Inc.
    Inventors: Jay B. Lichter, Marco Guida